U.S. Markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
4.50-0.10 (-2.17%)
At close: 3:59PM EDT
People also watch
OPXAIMUCCYCCNAVBCPRX
Full screen
Previous Close4.60
Open4.55
Bid4.50 x 8100
Ask4.60 x 1200
Day's Range4.50 - 4.61
52 Week Range2.25 - 5.09
Volume16,447
Avg. Volume18,947
Market Cap68.89M
Beta-0.88
PE Ratio (TTM)-5.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to NovaBay Pharmaceuticals, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NovaBay Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to NBY-US. Comparing the performance and risk of NovaBay Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cube7 days ago

    NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis NovaBay Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of NovaBay Pharmaceuticals, Inc. – Johnson & Johnson, Cempra, Inc., Oragenics, Inc., Tetraphase Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. (JNJ-US, CEMP-US, OGEN-US, TTPH-US and SNOA-US) that have also reported ... Read more (Read more...)

  • NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube3 months ago

    NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis NovaBay Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of NovaBay Pharmaceuticals, Inc. – KaloBios Pharmaceuticals Inc, Johnson & Johnson, Cempra, Inc., Oragenics, Inc., Tetraphase Pharmaceuticals, Inc., SIGA Technologies Inc and Sonoma Pharmaceuticals, Inc. (KBIO-US, JNJ-US, CEMP-US, OGEN-US, ... Read more (Read more...)